share_log

港股异动 | CRO概念股延续跌势 美联储不排除加息可能 国内创新药仍处调整周期

Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle

Zhitong Finance ·  Apr 19 10:57
CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347.HK) fell 7.94% to HK$28.4; Kingsley Biotech (01548.HK) fell 5.93% to HK$10.78; Kanglong Chemical (03759.HK) fell 4.83% to HK$8.47; and Pharmaceuticals (02359.HK) fell 4.5% to HK$32.9.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment